Clinical utilization of radiation therapy in Korea, 2016

被引:8
作者
Kim, Eunji [1 ]
Jang, Won Il [1 ]
Kim, Mi-Sook [1 ]
Paik, Eun Kyung [1 ]
Kim, Hee Jin [2 ]
Yoo, Hyung Jun [1 ]
Yang, Kwangmo [1 ]
Cho, Chul Koo [1 ]
机构
[1] Korea Inst Radiol & Med Sci, Dept Radiat Oncol, 75 Nowon Ro, Seoul 01812, South Korea
[2] Korea Inst Radiol & Med Sci, Strateg Planning Off, External Strategy Team, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
neoplasms; radiotherapy; statistics; infrastructure; Korea; IMAGE-GUIDED RADIOTHERAPY; CANCER;
D O I
10.1093/jrr/rrz095
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Radiotherapy (RT) is one of the primary cancer treatment modalities. To estimate the actual utilization of RT and infrastructure in Korea, the current study was performed. Data from 2012 to 2016 were extracted from the Health Insurance Review and Assessment Service. In addition, a nationwide survey was conducted to collect the statistics of RT facilities, equipment and human resources in Korea. The total number of patients treated with RT was 72 563 in 2016. The five cancers that were most commonly treated with RT in 2016 were breast, lung, colorectal, liver and prostate cancer. According to analyses of specific treatment modalities, the number of patients treated with intensity-modulated radiotherapy (IMRT), stereotactic radiation therapy (SRT) and proton therapy increased from 6670, 6306 and 50 in 2012 to 21584, 9048 and 703 in 2016, respectively. Ninety radiation oncology centers were working in 2015 and there were a total of 213 megavoltage teletherapy machines. In 2015, 310 patients were treated per megavoltage RT machine, 246 patients per radiation oncologist, 501 patients per medical physicist and 111 patients per radiotherapy technologist. In conclusion, the number of patients who underwent RT in Korea has increased steadily from 2012 to 2016. The IMRT utilization rate remarkably increased in 2016, and the number of patients treated with advanced treatment modalities such as IMRT, SRT and proton therapy is expected to increase.
引用
收藏
页码:249 / 256
页数:8
相关论文
共 28 条
  • [1] Modalities and techniques used for stereotactic radiotherapy, intensity-modulated radiotherapy, and image-guided radiotherapy: A 2018 survey by the Japan Society of Medical Physics
    Akino, Yuichi
    Tohyama, Naoki
    Akita, Kazuhiko
    Ishikawa, Masayori
    Kawamorita, Ryu
    Kurooka, Masahiko
    Sumida, Iori
    Nakaguchi, Yuji
    Miyaura, Kazunori
    Nakamura, Mitsuhiro
    [J]. PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2019, 64 : 182 - 187
  • [2] A national survey of the availability of intensity-modulated radiation therapy and stereotactic radiosurgery in Canada
    AlDuhaiby, Eman Z.
    Breen, Stephen
    Bissonnette, Jean-Pierre
    Sharpe, Michael
    Mayhew, Linda
    Tyldesley, Scott
    Wilke, Derek R.
    Hodgson, David C.
    [J]. RADIATION ONCOLOGY, 2012, 7
  • [3] 류성렬, 2004, Radiation oncology journal, V22, P234
  • [4] [Anonymous], J KOREAN SOC THER RA
  • [5] [Anonymous], 2018, GLOB CANC OBS
  • [6] Estimating the demand for radiotherapy from the evidence: A review of changes from 2003 to 2012
    Barton, Michael B.
    Jacob, Susannah
    Shafiq, Jesmin
    Wong, Karen
    Thompson, Stephen R.
    Hanna, Timothy P.
    Delaney, Geoff P.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 112 (01) : 140 - 144
  • [7] Bauml JM, 2019, JAMA ONCOL
  • [8] How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis
    Borras, Josep M.
    Lievens, Yolande
    Barton, Michael
    Corral, Julieta
    Ferlay, Jacques
    Bray, Freddie
    Grau, Cai
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 (01) : 5 - 11
  • [9] The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis
    Borras, Josep M.
    Lievens, Yolande
    Dunscombe, Peter
    Coffey, Mary
    Malicki, Julian
    Corral, Julieta
    Gasparotto, Chiara
    Defourny, Noemie
    Barton, Michael
    Verhoeven, Rob
    van Eycken, Liesbeth
    Primic-Zakelj, Maja
    Trojanowski, Maciej
    Strojan, Primoz
    Grau, Cai
    Kokobobo, Arianit
    Sedlmayer, Felix
    De Hertogh, Olivier
    Hadjieva, Tatiana
    Petera, Jiri
    Eriksen, Jesper Grau
    Jaal, Jana
    Azria, David
    Takacsi-Nagy, Zoltan
    Johannsson, Jakob
    Cunningham, Moya
    Atkocius, Vydmantas
    Untereiner, Michel
    Pirotta, Martin
    Karadjinovic, Vanja
    Levernes, Sverre
    Skladowski, Krystof
    Trigo, Maria Lurdes
    Segedin, Barbara
    Cabezas, Sonia Garcia
    Lagerlund, Magnus
    Pastoors, Bert
    Slotman, Ben
    Beardmore, Charlotte
    Smyth, Gaile
    Vaarkamp, Jaap
    Dyzmann-Sroka, Agnieszka
    Kubiak, Anna
    Henau, Kris
    Lemmens, Valery
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 116 (01) : 38 - 44
  • [10] Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
    Gomez, Daniel R.
    Tang, Chad
    Zhang, Jianjun
    Blumenschein, George R., Jr.
    Hernandez, Mike
    Lee, J. Jack
    Ye, Rong
    Palma, David A.
    Louie, Alexander, V
    Camidge, D. Ross
    Doebele, Robert C.
    Skoulidis, Ferdinandos
    Gaspar, Laurie E.
    Welsh, James W.
    Gibbons, Don L.
    Karam, Jose A.
    Kavanagh, Brian D.
    Tsao, Anne S.
    Sepesi, Boris
    Swisher, Stephen G.
    Heymach, John, V
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (18) : 1558 - 1565